Selected research
Market Outlook & Growth Opportunities
Global Pregnancy Point of Care Testing Market Outlook and Growth Opportunities 2026
Market perspective
The global Pregnancy Point of Care Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Pregnancy Point of Care Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pregnancy Point of Care Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pregnancy Point of Care Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Pregnancy Point of Care Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Pregnancy Point of Care Testing market include Wondfo, Ulti med Products, Swiss Precision Diagnostics, Runbio Biotech, Rohto, Quidel Corporation, NOW Diagnostics, NG Biotech and NFI Consumer Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Pregnancy Point of Care Testing market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pregnancy Point of Care Testing and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pregnancy Point of Care Testing sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pregnancy Point of Care Testing market size, projected growth trends, production technologies, key applications, and end-use industries.
Pregnancy Point of Care Testing Segment by Company
Wondfo
Ulti med Products
Swiss Precision Diagnostics
Runbio Biotech
Rohto
Quidel Corporation
NOW Diagnostics
NG Biotech
NFI Consumer Healthcare
EKF Diagnostics Holdings
Egens Biotech
Easy Healthcare
CIGA Healthcare
Church & Dwight
Biosynex
bioMerieux
Arax
Pregnancy Point of Care Testing Segment by Type
HCG Blood Test
HCG Urine Test
LH Urine Test
FSH Urine Test
Pregnancy Point of Care Testing Segment by Application
Hypermarkets & Supermarkets
Gynecology & Fertility Clinics
Pharmacies & Drugstores
Online Sales
Pregnancy Point of Care Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Pregnancy Point of Care Testing status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Pregnancy Point of Care Testing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pregnancy Point of Care Testing significant trends, drivers, influence factors in global and regions.
6. To analyze Pregnancy Point of Care Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pregnancy Point of Care Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pregnancy Point of Care Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pregnancy Point of Care Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pregnancy Point of Care Testing market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pregnancy Point of Care Testing industry.
Chapter 3: Detailed analysis of Pregnancy Point of Care Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Pregnancy Point of Care Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Pregnancy Point of Care Testing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- HCG Blood Test
- HCG Urine Test
- LH Urine Test
- FSH Urine Test
Applications
- Hypermarkets & Supermarkets
- Gynecology & Fertility Clinics
- Pharmacies & Drugstores
- Online Sales
Companies covered
- Wondfo
- Ulti med Products
- Swiss Precision Diagnostics
- Runbio Biotech
- Rohto
- Quidel Corporation
- NOW Diagnostics
- NG Biotech
- NFI Consumer Healthcare
- EKF Diagnostics Holdings
- Egens Biotech
- Easy Healthcare
- CIGA Healthcare
- Church & Dwight
- Biosynex
- bioMerieux
- Arax
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pregnancy Point of Care Testing Sales Value (2021-2032)
- 1.2.2 Global Pregnancy Point of Care Testing Sales Volume (2021-2032)
- 1.2.3 Global Pregnancy Point of Care Testing Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Pregnancy Point of Care Testing Market Dynamics
- 2.1 Pregnancy Point of Care Testing Industry Trends
- 2.2 Pregnancy Point of Care Testing Industry Drivers
- 2.3 Pregnancy Point of Care Testing Industry Opportunities and Challenges
- 2.4 Pregnancy Point of Care Testing Industry Restraints
3 Pregnancy Point of Care Testing Market by Company
- 3.1 Global Pregnancy Point of Care Testing Company Revenue Ranking in 2025
- 3.2 Global Pregnancy Point of Care Testing Revenue by Company (2021-2026)
- 3.3 Global Pregnancy Point of Care Testing Sales Volume by Company (2021-2026)
- 3.4 Global Pregnancy Point of Care Testing Average Price by Company (2021-2026)
- 3.5 Global Pregnancy Point of Care Testing Company Ranking (2024-2026)
- 3.6 Global Pregnancy Point of Care Testing Company Manufacturing Base and Headquarters
- 3.7 Global Pregnancy Point of Care Testing Company Product Type and Application
- 3.8 Global Pregnancy Point of Care Testing Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Pregnancy Point of Care Testing Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Pregnancy Point of Care Testing Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Pregnancy Point of Care Testing Market by Type
- 4.1 Pregnancy Point of Care Testing Type Introduction
- 4.1.1 HCG Blood Test
- 4.1.2 HCG Urine Test
- 4.1.3 LH Urine Test
- 4.1.4 FSH Urine Test
- 4.2 Global Pregnancy Point of Care Testing Sales Volume by Type
- 4.2.1 Global Pregnancy Point of Care Testing Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pregnancy Point of Care Testing Sales Volume by Type (2021-2032)
- 4.2.3 Global Pregnancy Point of Care Testing Sales Volume Share by Type (2021-2032)
- 4.3 Global Pregnancy Point of Care Testing Sales Value by Type
- 4.3.1 Global Pregnancy Point of Care Testing Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pregnancy Point of Care Testing Sales Value by Type (2021-2032)
- 4.3.3 Global Pregnancy Point of Care Testing Sales Value Share by Type (2021-2032)
5 Pregnancy Point of Care Testing Market by Application
- 5.1 Pregnancy Point of Care Testing Application Introduction
- 5.1.1 Hypermarkets & Supermarkets
- 5.1.2 Gynecology & Fertility Clinics
- 5.1.3 Pharmacies & Drugstores
- 5.1.4 Online Sales
- 5.2 Global Pregnancy Point of Care Testing Sales Volume by Application
- 5.2.1 Global Pregnancy Point of Care Testing Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pregnancy Point of Care Testing Sales Volume by Application (2021-2032)
- 5.2.3 Global Pregnancy Point of Care Testing Sales Volume Share by Application (2021-2032)
- 5.3 Global Pregnancy Point of Care Testing Sales Value by Application
- 5.3.1 Global Pregnancy Point of Care Testing Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pregnancy Point of Care Testing Sales Value by Application (2021-2032)
- 5.3.3 Global Pregnancy Point of Care Testing Sales Value Share by Application (2021-2032)
6 Pregnancy Point of Care Testing Regional Sales and Value Analysis
- 6.1 Global Pregnancy Point of Care Testing Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pregnancy Point of Care Testing Sales by Region (2021-2032)
- 6.2.1 Global Pregnancy Point of Care Testing Sales by Region: 2021-2026
- 6.2.2 Global Pregnancy Point of Care Testing Sales by Region (2027-2032)
- 6.3 Global Pregnancy Point of Care Testing Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Pregnancy Point of Care Testing Sales Value by Region (2021-2032)
- 6.4.1 Global Pregnancy Point of Care Testing Sales Value by Region: 2021-2026
- 6.4.2 Global Pregnancy Point of Care Testing Sales Value by Region (2027-2032)
- 6.5 Global Pregnancy Point of Care Testing Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Pregnancy Point of Care Testing Sales Value (2021-2032)
- 6.6.2 North America Pregnancy Point of Care Testing Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Pregnancy Point of Care Testing Sales Value (2021-2032)
- 6.7.2 Europe Pregnancy Point of Care Testing Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Pregnancy Point of Care Testing Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Pregnancy Point of Care Testing Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Pregnancy Point of Care Testing Sales Value (2021-2032)
- 6.9.2 South America Pregnancy Point of Care Testing Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Pregnancy Point of Care Testing Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Pregnancy Point of Care Testing Sales Value Share by Country, 2025 VS 2032
7 Pregnancy Point of Care Testing Country-level Sales and Value Analysis
- 7.1 Global Pregnancy Point of Care Testing Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Pregnancy Point of Care Testing Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Pregnancy Point of Care Testing Sales by Country (2021-2032)
- 7.3.1 Global Pregnancy Point of Care Testing Sales by Country (2021-2026)
- 7.3.2 Global Pregnancy Point of Care Testing Sales by Country (2027-2032)
- 7.4 Global Pregnancy Point of Care Testing Sales Value by Country (2021-2032)
- 7.4.1 Global Pregnancy Point of Care Testing Sales Value by Country (2021-2026)
- 7.4.2 Global Pregnancy Point of Care Testing Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.9.2 France Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.16.2 China Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.19.2 India Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Pregnancy Point of Care Testing Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Pregnancy Point of Care Testing Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Pregnancy Point of Care Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Wondfo
- 8.1.1 Wondfo Company Information
- 8.1.2 Wondfo Business Overview
- 8.1.3 Wondfo Pregnancy Point of Care Testing Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Wondfo Pregnancy Point of Care Testing Product Portfolio
- 8.1.5 Wondfo Recent Developments
- 8.2 Ulti med Products
- 8.2.1 Ulti med Products Company Information
- 8.2.2 Ulti med Products Business Overview
- 8.2.3 Ulti med Products Pregnancy Point of Care Testing Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Ulti med Products Pregnancy Point of Care Testing Product Portfolio
- 8.2.5 Ulti med Products Recent Developments
- 8.3 Swiss Precision Diagnostics
- 8.3.1 Swiss Precision Diagnostics Company Information
- 8.3.2 Swiss Precision Diagnostics Business Overview
- 8.3.3 Swiss Precision Diagnostics Pregnancy Point of Care Testing Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Swiss Precision Diagnostics Pregnancy Point of Care Testing Product Portfolio
- 8.3.5 Swiss Precision Diagnostics Recent Developments
- 8.4 Runbio Biotech
- 8.4.1 Runbio Biotech Company Information
- 8.4.2 Runbio Biotech Business Overview
- 8.4.3 Runbio Biotech Pregnancy Point of Care Testing Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Runbio Biotech Pregnancy Point of Care Testing Product Portfolio
- 8.4.5 Runbio Biotech Recent Developments
- 8.5 Rohto
- 8.5.1 Rohto Company Information
- 8.5.2 Rohto Business Overview
- 8.5.3 Rohto Pregnancy Point of Care Testing Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Rohto Pregnancy Point of Care Testing Product Portfolio
- 8.5.5 Rohto Recent Developments
- 8.6 Quidel Corporation
- 8.6.1 Quidel Corporation Company Information
- 8.6.2 Quidel Corporation Business Overview
- 8.6.3 Quidel Corporation Pregnancy Point of Care Testing Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Quidel Corporation Pregnancy Point of Care Testing Product Portfolio
- 8.6.5 Quidel Corporation Recent Developments
- 8.7 NOW Diagnostics
- 8.7.1 NOW Diagnostics Company Information
- 8.7.2 NOW Diagnostics Business Overview
- 8.7.3 NOW Diagnostics Pregnancy Point of Care Testing Sales, Value and Gross Margin (2021-2026)
- 8.7.4 NOW Diagnostics Pregnancy Point of Care Testing Product Portfolio
- 8.7.5 NOW Diagnostics Recent Developments
- 8.8 NG Biotech
- 8.8.1 NG Biotech Company Information
- 8.8.2 NG Biotech Business Overview
- 8.8.3 NG Biotech Pregnancy Point of Care Testing Sales, Value and Gross Margin (2021-2026)
- 8.8.4 NG Biotech Pregnancy Point of Care Testing Product Portfolio
- 8.8.5 NG Biotech Recent Developments
- 8.9 NFI Consumer Healthcare
- 8.9.1 NFI Consumer Healthcare Company Information
- 8.9.2 NFI Consumer Healthcare Business Overview
- 8.9.3 NFI Consumer Healthcare Pregnancy Point of Care Testing Sales, Value and Gross Margin (2021-2026)
- 8.9.4 NFI Consumer Healthcare Pregnancy Point of Care Testing Product Portfolio
- 8.9.5 NFI Consumer Healthcare Recent Developments
- 8.10 EKF Diagnostics Holdings
- 8.10.1 EKF Diagnostics Holdings Company Information
- 8.10.2 EKF Diagnostics Holdings Business Overview
- 8.10.3 EKF Diagnostics Holdings Pregnancy Point of Care Testing Sales, Value and Gross Margin (2021-2026)
- 8.10.4 EKF Diagnostics Holdings Pregnancy Point of Care Testing Product Portfolio
- 8.10.5 EKF Diagnostics Holdings Recent Developments
- 8.11 Egens Biotech
- 8.11.1 Egens Biotech Company Information
- 8.11.2 Egens Biotech Business Overview
- 8.11.3 Egens Biotech Pregnancy Point of Care Testing Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Egens Biotech Pregnancy Point of Care Testing Product Portfolio
- 8.11.5 Egens Biotech Recent Developments
- 8.12 Easy Healthcare
- 8.12.1 Easy Healthcare Company Information
- 8.12.2 Easy Healthcare Business Overview
- 8.12.3 Easy Healthcare Pregnancy Point of Care Testing Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Easy Healthcare Pregnancy Point of Care Testing Product Portfolio
- 8.12.5 Easy Healthcare Recent Developments
- 8.13 CIGA Healthcare
- 8.13.1 CIGA Healthcare Company Information
- 8.13.2 CIGA Healthcare Business Overview
- 8.13.3 CIGA Healthcare Pregnancy Point of Care Testing Sales, Value and Gross Margin (2021-2026)
- 8.13.4 CIGA Healthcare Pregnancy Point of Care Testing Product Portfolio
- 8.13.5 CIGA Healthcare Recent Developments
- 8.14 Church & Dwight
- 8.14.1 Church & Dwight Company Information
- 8.14.2 Church & Dwight Business Overview
- 8.14.3 Church & Dwight Pregnancy Point of Care Testing Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Church & Dwight Pregnancy Point of Care Testing Product Portfolio
- 8.14.5 Church & Dwight Recent Developments
- 8.15 Biosynex
- 8.15.1 Biosynex Company Information
- 8.15.2 Biosynex Business Overview
- 8.15.3 Biosynex Pregnancy Point of Care Testing Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Biosynex Pregnancy Point of Care Testing Product Portfolio
- 8.15.5 Biosynex Recent Developments
- 8.16 bioMerieux
- 8.16.1 bioMerieux Company Information
- 8.16.2 bioMerieux Business Overview
- 8.16.3 bioMerieux Pregnancy Point of Care Testing Sales, Value and Gross Margin (2021-2026)
- 8.16.4 bioMerieux Pregnancy Point of Care Testing Product Portfolio
- 8.16.5 bioMerieux Recent Developments
- 8.17 Arax
- 8.17.1 Arax Company Information
- 8.17.2 Arax Business Overview
- 8.17.3 Arax Pregnancy Point of Care Testing Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Arax Pregnancy Point of Care Testing Product Portfolio
- 8.17.5 Arax Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pregnancy Point of Care Testing Value Chain Analysis
- 9.1.1 Pregnancy Point of Care Testing Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pregnancy Point of Care Testing Sales Mode & Process
- 9.2 Pregnancy Point of Care Testing Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pregnancy Point of Care Testing Distributors
- 9.2.3 Pregnancy Point of Care Testing Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst